Maddy summaryS 1548 bans specific harmful chemicals from menstrual products sold in New York State. It prohibits manufacturers from intentionally adding substances like lead, mercury, formaldehyde, triclosan, and PFAS (a class of chemicals including Teflon-like compounds) to products such as tampons, pads, and menstrual cups. The bill takes immediate effect for all intentionally added restricted substances, with a 2029 deadline for setting science-based limits on any remaining traces of these chemicals. This directly affects all companies producing or selling menstrual products in New York, requiring them to reformulate products to remove these substances.
Sen. Cordell Cleare
Sponsored bills
Requires the office of children and family services to provide luggage to youth in foster care; provides that such luggage shall be distributed to social services districts for distribution to foster care youth; requires the office of children and family services to submit an annual report to the governor and the legislature about the distribution of luggage to foster care youth.
Requires a caller making a report of suspected child abuse or maltreatment to the central register to leave their name and contact information; prohibits the office of children and family services from releasing information identifying a person who made such a report.
Maddy summaryS 123 bans the sale of infant walkers by all sellers (manufacturers, distributors, retailers, and secondhand dealers) in New York State. It also restricts the use of infant walkers in child care facilities, requiring medical necessity approval from a professional for any exception. Child care facilities must receive plain-language notice about the ban and follow rules set by the Office of Children and Family Services. The law allows the attorney general to enforce the ban through injunctions and impose civil penalties for violations.
Adds certain properties located in a city of one million or more to the definition of a qualified historic home for the historic homeownership rehabilitation credit.
Authorizes the removal of police officer candidates from an eligible list when such candidate does not meet psychological fitness requirements or lacks good moral character standards.
Maddy summaryThis bill moves the Amistad Commission from the State Department to the State Education Department. The commission, which focuses on promoting education about the African slave trade, slavery in America, and African-American contributions, will now be managed by the Education Department rather than the State Department. This transfer shifts administrative responsibility for the commission's work - such as developing educational resources, recognizing schools teaching African-American history, and advising on curriculum - to the Education Department. The bill is now law (Chapter 542, signed November 21, 2025).
Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
Prohibits discrimination against and harassment or bullying of students by other students on school property or at a school function; requires schools to investigate reports of bullying; requires schools to adopt a written, plain-language anti-bullying and harassment policy; requires school employees to report incidents of bullying or harassment.
Maddy summaryThis bill requires most health insurance plans to cover contraceptive services provided by pharmacists without cost-sharing. It mandates coverage for all FDA-approved contraceptives (including over-the-counter options), emergency contraception, patient counseling, and follow-up care like device insertion/removal. Plans must allow dispensing up to 12 months of contraceptives at once and reimburse pharmacists the same rate as other healthcare providers. The law applies to group/blanket health insurance policies issued or renewed on or after January 1, 2025, directly affecting insured individuals and pharmacists providing these services.